Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1167557 Greenwich, CT
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,384,513
+$4,822,716 QoQ
Shares Held
2,356,429
+18.1% QoQ
Ownership
0.671%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 242 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. NUVB ranks #38 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in NUVB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,384,513 2,356,429
2026-03-31 $8,561,797 1,995,758
2025-12-31 $14,955,724 1,669,166
2025-09-30 $7,526,579 2,034,211
2025-06-30 $2,217,718 1,137,292
2025-03-31 $238,318 135,409
2024-12-31 $2,184,814 821,359
2024-09-30 $1,700,180 742,437
2024-06-30 $325,821 111,583
2024-03-31 $66,793 18,350